Cormedix Inc (STU:19KA)
€ 9.65 0.25 (2.66%) Market Cap: 601.04 Mil Enterprise Value: 558.66 Mil PE Ratio: 0 PB Ratio: 10.17 GF Score: 52/100

Q1 2021 CorMedix Inc Earnings Call Transcript

May 13, 2021 / 08:30PM GMT
Release Date Price: €6.25 (-5.30%)
Operator

Good afternoon, and welcome to the CorMedix first quarter earnings conference call. Today's conference call is being recorded. (Operator Instructions) At this time, I would like to turn this conference call over to Mr. Daniel Ferry from LifeSci Advisors. Please go ahead. You may begin.

Daniel Ferry
LifeSci Advisors, LLC - MD & Relationship Manager

Good afternoon, and welcome to the CorMedix First Quarter 2021 Earnings Conference Call. Leading the call today is Khoso Baluch, Chief Executive Officer of CorMedix. He is joined by Dr. Phoebe Mounts, Executive Vice President and General Counsel; Dr. Matt David, Executive Vice President and Chief Financial Officer; Ms. Liz Masson-Hurlburt, Executive Vice President for Clinical Operations; and Mr. Tom Nusbickel, Executive Vice President and Chief Commercial Officer.

Before we begin, I would like to remind everyone that during the call, management may make what are known as forward-looking statements within the meanings set forth in the private Securities Litigation Reform Act of 1995. These statements are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot